A drug commonly used to shrink enlarged prostate glands also increases the accuracy of the test used to detect aggressive forms of prostate cancer, Washington University researchers have found. Dr.

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland that sits below the bladder and helps produce fluid for semen. Although ...

Prostate cancer is one of the most frequently diagnosed cancers in men yet is often highly treatable when detected early. It originates in the prostate gland, located between the bladder and the penis ...

As prostate cancer cases even among youngsters are increasing, a new at-home saliva test to help identify high-risk patients is here. According to experts, this can help find out the chances of ...

Research shows that ejaculating as much as once every day can really limit the chances, while another study suggests a ...

Men's health disease, on prostate cancer or mental illness concept with male patient having consultation with doctor or psychiatrist working on diagnostic examination in medical clinic or hospital ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

A diet rich in vegetables and probiotics could help slow the growth of low-risk prostate cancer, a new study suggests. Researchers found that specially designed supplements and probiotics appeared to ...

Apprehension, embarrassment regarding initiating a discussion on sexual health with clinicians cited as barriers to seeking help for sexual issues following prostate cancer treatment in men.

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...